# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-048893
Filing Date
2024-12-05
Accepted
2024-12-05 16:37:48
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefa14a.htm | DEFA14A | 59643
2 |  | formdefa14a_001.jpg | GRAPHIC | 5858
3 |  | formdefa14a_002.jpg | GRAPHIC | 343453
4 |  | formdefa14a_003.jpg | GRAPHIC | 361835
| Complete submission text file | 0001493152-24-048893.txt |  | 1040587

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-27072 | Film No.: 241529609
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)